Program:
Advances in Therapeutic Application and Development
Novel Endothelin Receptor Antagonists
Targets for Drug Discovery
Clinical Trial Advances
Animal Models of Endothelin
Mechanisms and Regulation of ET
Registration :
For further information contact IBC at: 1-508-481-6400,
fax: 1-508-481-7911, on-line: http://www.ibcusa.com/conf/endothelin
or e-mail: reg@ibcusa.com
Deadline for Abstracts: Poster Abstracts: May 26, 1997
Email for Requests and Registration: reg@ibcusa.com